F2G and Shionogi Present Full Set of Pivotal Phase 2b Study Data at Trends in Medical Mycology (TIMM) 2023, Demonstrating Positive Therapeutic Responses in Patients With Invasive Fungal Infections Treated With Olorofim oral – Technology today
F2G and Shionogi Present Full Set of Pivotal Phase 2b Study Data at Trends in Medical Mycology (TIMM) 2023, Demonstrating Positive Therapeutic Responses in Patients With Invasive Fungal Infections Treated With Oral Olorofim – Technology Today – EIN Presswire
Trusted News Since 1995
A service for professionals in the technology industry · Saturday October 21, 2023